Provided by Tiger Trade Technology Pte. Ltd.

Rigel Pharmaceuticals

47.50
+1.322.86%
Post-market: 47.500.00000.00%19:30 EDT
Volume:205.51K
Turnover:9.71M
Market Cap:887.29M
PE:2.89
High:47.85
Open:46.15
Low:46.15
Close:46.18
52wk High:52.24
52wk Low:24.95
Shares:18.68M
Float Shares:14.85M
Volume Ratio:0.79
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):16.45
EPS(LYR):19.48
ROE:126.90%
ROA:14.95%
PB:2.09
PE(LYR):2.44

Loading ...

May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 02, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2023

Major Issues Report

8-K - Current report
Mar 07, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2023

Major Issues Report

8-K - Current report